Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa

被引:17
|
作者
Berlier, Monique [1 ]
Barry, Rodrigue [2 ]
Shadid, John [3 ]
Sirica, Coimbra [4 ]
Brunier, Alison [5 ]
Hasan, Hayatee [6 ]
Bouma, Enricke [1 ]
机构
[1] PATH, Meningitis Vaccine Project, Ferney Voltaire, France
[2] WHO, Intercountry Support Team West Africa, Ouagadougou, Burkina Faso
[3] UN Childrens Fund, West & Cent Africa Reg Off, Dakar, Senegal
[4] Burness Commun, Bethesda, MD USA
[5] WHO, Dept Commun Capac Bldg, CH-1211 Geneva, Switzerland
[6] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland
关键词
advocacy and communication; messaging; vaccine introduction; meningitis belt; crisis communication; CONJUGATE VACCINE; MENINGITIS; TEMPERATURE; BENEFITS; CHAD;
D O I
10.1093/cid/civ493
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A new group A meningococcal conjugate vaccine was developed to eliminate deadly meningitis epidemics in sub-Saharan Africa. Methods. From the outset of the project, advocacy and communication strategies were developed and adjusted as the project evolved in Europe, Africa, India, and the United States. Communications efforts were evidence-based, and involved partnerships with the media and various stakeholders including African ministries of health, the World Health Organization, UNICEF, Gavi, the Centers for Disease Control and Prevention, and M,decins Sans FrontiSres. Results. The implementation of an integrated communication strategy ensured the active cooperation of stakeholders while providing an organized and defined format for the dissemination of project-related developmental activities and the successful introduction of the vaccine. Conclusions. Early in the project, a communications strategy that engaged stakeholders and potential supporters was developed. The strategy was implemented and adapted as the project matured. Linked communication proved to be key to the successful wide-scale introduction of the PsA-TT (MenAfriVac) vaccine in Africa.
引用
收藏
页码:S451 / S458
页数:8
相关论文
共 50 条
  • [21] WHO Strategic Advisory Group of Experts on Immunization recommendations for use of a novel pentavalent meningococcal ACWXY vaccine: a critical step towards ending meningococcal epidemics in Africa
    McNamara, Lucy A.
    Neatherlin, John
    JOURNAL OF TRAVEL MEDICINE, 2024, 31 (01)
  • [22] The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment
    Maiden, Martin Christopher James
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [23] Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017
    Fernandez, Katya
    Lingani, Clement
    Aderinola, Olaolu Moses
    Goumbi, Kadade
    Bicaba, Brice
    Edea, Zewdu Assefa
    Glele, Clement
    Sarkodie, Badu
    Tamekloe, Agbeko
    Ngomba, Armelle
    Djingarey, Mamoudou
    Bwaka, Ado
    Perea, William
    Ronveaux, Olivier
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S225 - S232
  • [24] Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVacR)
    Kulkarni, Prasad S.
    Jadhav, Suresh S.
    LaForce, F. Marc
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) : 1103 - 1106
  • [25] An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine
    Chandramohan, Daniel
    Hodgson, Abraham
    Coleman, Paul
    Baiden, Rita
    Asante, Kwaku
    Awine, Elizabeth
    Owusu-Agyei, Seth
    Boutriau, Dominique
    Nelson, Christopher B.
    Greenwood, Brain
    VACCINE, 2007, 25 : A83 - A91
  • [26] Financing dengue vaccine introduction in the Americas: challenges and opportunities
    Constenla, Dagna
    Clark, Samantha
    EXPERT REVIEW OF VACCINES, 2016, 15 (04) : 547 - 559
  • [27] MenQuadfi (MenACWY-TT): A New Vaccine for Meningococcal Serogroups ACWY
    Huston, Jessica
    Galicia, Kevin
    Egelund, Eric F.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (06) : 727 - 735
  • [28] Review: Impact, Challenges, and Future Projections of Vaccine Trials in Africa
    Idoko, Olubukola T.
    Kochhar, Sonali
    Agbenyega, Tsiri E.
    Ogutu, Bernhards
    Ota, Martin O. C.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 88 (03) : 414 - 419
  • [29] Vaccine development as a 'doable problem': The case of the meningococcal A vaccines 1962-1969
    Baylac-Paouly, Baptiste
    STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE PART C-STUDIES IN HISTORY AND PHILOSOPHY OF BIOLOGICAL AND BIOMEDICAL SCIENCES, 2019, 74 : 7 - 14
  • [30] Development and Immunogenicity of a Brazilian Glycoconjugate vaccine against Meningococcal W in a Pilot Scale
    Iaralice Medeiros de Souza
    Milton Neto da Silva
    Renata Chagas Bastos
    Denise da Silva Gomes Pereira
    Elza Cristina Schott Figueira
    Ellen Jessouroun
    Maria de Lourdes Moura Leal
    Eliana Barreto-Bergter
    Ivna Alana Freitas Brasileiro da Silveira
    Glycoconjugate Journal, 2021, 38 : 539 - 549